{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:00:39Z","timestamp":1789646439962,"version":"4.0.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Antimicrobial resistance poses a critical challenge to global public health, exacerbating morbidity and mortality associated with bacterial infections. This study addresses the urgent need for novel antibacterial agents by exploring the design and synthesis of quinazoline-piperazine phosphorodiamidate hybrids (<jats:bold>6a-g)<\/jats:bold> as potential DNA gyrase inhibitors. Antibacterial activity was evaluated using the agar well diffusion method, revealing significant inhibition zones for compounds <jats:bold>6f<\/jats:bold>,<jats:bold> 6\u00a0g<\/jats:bold>,<jats:bold> 6a<\/jats:bold>, and <jats:bold>6c<\/jats:bold> compared to the standard drug Amoxyclav. Minimum inhibitory concentration (MIC) measurements further supported the potent antibacterial effects of these compounds. Additionally, compounds <jats:bold>6f<\/jats:bold>,<jats:bold> 6\u00a0g<\/jats:bold>, and <jats:bold>6a<\/jats:bold> exhibited notable antifungal activity superior to Fluconazole. Molecular docking simulations against DNA gyrase demonstrated strong binding affinities of compounds <jats:bold>6f<\/jats:bold> and <jats:bold>6a<\/jats:bold> with dock scores surpassing that of a standard antibiotic, ciprofloxacin. Detailed analysis of binding interactions highlighted key residues involved in stabilizing the ligand-protein complexes, providing insights into their mechanism of action. Furthermore, in silico ADMET prediction studies revealed that the targeted analogs satisfied the drug like characteristics of CNS acting drugs against antimicrobial diseases.<\/jats:p>","DOI":"10.1038\/s41598-025-11516-7","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:22:16Z","timestamp":1759242136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Design, synthesis, and antimicrobial evaluation of novel quinazoline piperazine phosphorodiamidate hybrids as potent DNA gyrase inhibitors"],"prefix":"10.1038","volume":"15","author":[{"given":"Suresh Babu","family":"Donka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajitha","family":"Kethineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bala Yesu","family":"Valaparla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Bheemreddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunadh D.","family":"Meti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam A.","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Subbaiah","family":"Kotakadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Vatturu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasulu","family":"Doddaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"11516_CR1","doi-asserted-by":"publisher","first-page":"100081","DOI":"10.1016\/j.glmedi.2024.100081","volume":"2","author":"K Sirwan","year":"2024","unstructured":"Sirwan, K. et al. Antimicrobial resistance: impacts, challenges, and future prospects. J. Med. Surg. Public. Health. 2, 100081. https:\/\/doi.org\/10.1016\/j.glmedi.2024.100081 (2024).","journal-title":"J. Med. Surg. Public. Health"},{"key":"11516_CR2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2174\/1568026622666220307144015","volume":"22","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. The antibacterial activity of Quinazoline and Quinazolinone hybrids. Curr. Top. Med. Chem. 22, 1035\u20131044. https:\/\/doi.org\/10.2174\/1568026622666220307144015 (2022).","journal-title":"Curr. Top. Med. Chem."},{"key":"11516_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2174\/0929867330666230123143458","volume":"31","author":"A Nazli","year":"2024","unstructured":"Nazli, A., Qiu, J., Tang, Y. & He, Z. Y. Recent advances and techniques for identifying novel antibacterial targets. Curr. Med. Chem. 31, 464\u2013501. https:\/\/doi.org\/10.2174\/0929867330666230123143458 (2024).","journal-title":"Curr. Med. Chem."},{"key":"11516_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11030-024-10830-y","volume":"29","author":"RM Hassan","year":"2025","unstructured":"Hassan, R. M. et al. Design and synthesis of new Quinazolinone derivatives: investigation of antimicrobial and biofilm Inhibition effects. Mol. Divers. 29, 21\u201342. https:\/\/doi.org\/10.1007\/s11030-024-10830-y (2025).","journal-title":"Mol. Divers."},{"key":"11516_CR5","doi-asserted-by":"publisher","first-page":"141065","DOI":"10.1016\/j.molstruc.2024.141065","volume":"1326","author":"K Muhammad","year":"2025","unstructured":"Muhammad, K. et al. Azhar, A. Anticancer activity of fused quinazoline-quinazolinone: synthesis, biological evaluations, and computational studies. J. Mol. Struct. 1326, 141065. https:\/\/doi.org\/10.1016\/j.molstruc.2024.141065 (2025).","journal-title":"J. Mol. Struct."},{"key":"11516_CR6","doi-asserted-by":"publisher","first-page":"115831","DOI":"10.1016\/j.ejmech.2023.115831","volume":"261","author":"Z Shengchao","year":"2023","unstructured":"Shengchao, Z. et al. Ji. Design, synthesis, and structure-activity relationships of a novel class of Quinazoline derivatives as coronavirus inhibitors. Eur. J. Med. Chem. 261, 115831. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115831 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"11516_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/chemengineering6060094","volume":"6","author":"MF Zayed","year":"2022","unstructured":"Zayed, M. F. Medicinal chemistry of Quinazolines as analgesic and Anti-Inflammatory agents. Chem. Eng. 6, 6, 94. https:\/\/doi.org\/10.3390\/chemengineering6060094 (2022).","journal-title":"Chem. Eng."},{"key":"11516_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3109\/14756366.2013.845820","volume":"29","author":"U Mujeeb","year":"2014","unstructured":"Mujeeb, U. et al. Synthesis and characterization of Quinazoline derivatives: search for hybrid molecule as diuretic and antihypertensive agents. J. Enzyme Inhib. Med. Chem. 29, 5, 733\u2013743. https:\/\/doi.org\/10.3109\/14756366.2013.845820 (2014).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"11516_CR9","doi-asserted-by":"publisher","first-page":"131384","DOI":"10.1016\/j.molstruc.2021.131384","volume":"1248","author":"S Rameshwar","year":"2022","unstructured":"Rameshwar, S. et al. Quinazoline: an update on current status against convulsions. J. Mol. Struct. 1248, 131384. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131384 (2022).","journal-title":"J. Mol. Struct."},{"key":"11516_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.9734\/bpi\/rdcbr\/v7\/2769","volume":"7","author":"K Praveen","year":"2024","unstructured":"Praveen, K. & Girijasastry, K. Synthesis and evaluation of In-vitro and In-vivo antioxidant properties: novel 2-phenyl-3-Sustituted Quinazoline-4-ones. Recent. Developments Chem. Biochem. Res. 7, 23, 78\u201397. https:\/\/doi.org\/10.9734\/bpi\/rdcbr\/v7\/2769 (2024).","journal-title":"Recent. Developments Chem. Biochem. Res."},{"key":"11516_CR11","doi-asserted-by":"publisher","first-page":"107340","DOI":"10.1016\/j.bioorg.2024.107340","volume":"147","author":"W Jin-Si","year":"2024","unstructured":"Jin-Si, W. et al. Structure-guided design of novel biphenyl-quinazoline derivatives as potent non-nucleoside reverse transcriptase inhibitors featuring improved anti-resistance, selectivity, and solubility. Bioorg. Chem. 147, 107340. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107340 (2024).","journal-title":"Bioorg. Chem."},{"key":"11516_CR12","doi-asserted-by":"publisher","unstructured":"Ravindar, L., Siti, Aishah, H., Rakesh, K. & Nurul, P. I, H. Recent developments in antimalarial activities of 4-aminoquinoline derivatives. European Journal of Medicinal Chemistry.256, 115458 (2023). https:\/\/doi.org\/10.1016\/j.ejmech.2023.115458","DOI":"10.1016\/j.ejmech.2023.115458"},{"key":"11516_CR13","doi-asserted-by":"publisher","unstructured":"Vishwanath, H., Sangappa, T., Hanamant, B. S. & Dharyappa, T. Quinazoline scaffold as a target for combating microbial resistance: Synthesis and antimicrobial profiling of quinazoline derivatives. Result. Chem. 13, 101955. https:\/\/doi.org\/10.1016\/j.rechem.2024.101955 (2025).","DOI":"10.1016\/j.rechem.2024.101955"},{"key":"11516_CR14","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1021\/jacsau.4c00731","volume":"4","author":"F Amanda","year":"2024","unstructured":"Amanda, F. et al. Jiyong, hong. Design and evaluation of pyridinyl sulfonyl piperazine LpxH inhibitors with potent antibiotic activity against enterobacterales. JACS Au. 4, 11, 4383\u20134393. https:\/\/doi.org\/10.1021\/jacsau.4c00731 (2024).","journal-title":"JACS Au"},{"key":"11516_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1134\/S1068162023050096","volume":"49","author":"B Aktar","year":"2023","unstructured":"Aktar, B. Anticancer activities of piperazine ringed chalcone compounds and in Silico studies. Russ J. Bioorg. Chem. 49, 1023\u20131033. https:\/\/doi.org\/10.1134\/S1068162023050096 (2023).","journal-title":"Russ J. Bioorg. Chem."},{"key":"11516_CR16","doi-asserted-by":"publisher","first-page":"116202","DOI":"10.1016\/j.jpba.2024.116202","volume":"246","author":"A Maria","year":"2024","unstructured":"Maria, A. et al. New piperazine and morpholine derivatives: mass spectrometry characterization and evaluation of their antimicrobial activity. J. Pharm. Biomed. Anal. 246, 116202. https:\/\/doi.org\/10.1016\/j.jpba.2024.116202 (2024).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"11516_CR17","doi-asserted-by":"publisher","first-page":"16931","DOI":"10.1039\/D1RA02426D","volume":"11","author":"G Lanchang","year":"2021","unstructured":"Lanchang, G. et al. Synthesis and biological evaluation of a new class of multi-target heterocycle piperazine derivatives as potential antipsychotics. RSC Adv. 11, 16931\u201316941. https:\/\/doi.org\/10.1039\/D1RA02426D (2021).","journal-title":"RSC Adv."},{"key":"11516_CR18","doi-asserted-by":"publisher","first-page":"16426","DOI":"10.1021\/acs.jmedchem.3c01876","volume":"66","author":"G Shenghua","year":"2023","unstructured":"Shenghua, G. et al. Peng, zhan. Design, synthesis, and biological evaluation of trisubstituted piperazine derivatives as noncovalent severe acute respiratory syndrome coronavirus 2 main protease inhibitors with improved antiviral activity and favorable druggability. J. Med. Chem. 66, 23, 16426\u201316440. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01876 (2023).","journal-title":"J. Med. Chem."},{"key":"11516_CR19","doi-asserted-by":"publisher","first-page":"138634","DOI":"10.1016\/j.molstruc.2024.138634","volume":"1312","author":"K Vinuta","year":"2024","unstructured":"Vinuta, K. et al. Synthesis, anti-inflammatory, antibacterial, and antioxidant evaluation of novel pyrazole-linked hydrazone derivatives. J. Mol. Struct. 1312, 138634. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138634 (2024).","journal-title":"J. Mol. Struct."},{"key":"11516_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/slct.202300551","volume":"8","author":"B Yongchang","year":"2023","unstructured":"Yongchang, B. et al. Gu. Effective synthesis and Anti-Mycobacterial activity of Isoxazole-Substituted piperazine derivatives. Chem. Select. 8, 18. https:\/\/doi.org\/10.1002\/slct.202300551 (2023).","journal-title":"Chem. Select"},{"key":"11516_CR21","doi-asserted-by":"publisher","unstructured":"Saadeh, H. et al. A. Novel 5-Nitroimidazole and 5-Nitrothiazole Piperazine Derivatives and Their Antiparasitic Activity. Chemistry Select. 2, 5684\u20135687 (2017). (2017). https:\/\/doi.org\/10.1002\/slct.201700348","DOI":"10.1002\/slct.201700348"},{"key":"11516_CR22","doi-asserted-by":"publisher","first-page":"132587","DOI":"10.1016\/j.molstruc.2022.132587","volume":"1257","author":"P Rohit","year":"2022","unstructured":"Rohit, P. et al. Chawla., bhupinder, kumar. Design, synthesis and evaluation of piperazine clubbed 1,2,4-triazine derivatives as potent anticonvulsant agents. J. Mol. Struct. 1257, 132587. https:\/\/doi.org\/10.1016\/j.molstruc.2022.132587 (2022).","journal-title":"J. Mol. Struct."},{"key":"11516_CR23","doi-asserted-by":"publisher","first-page":"115545","DOI":"10.1016\/j.ejmech.2023.115545","volume":"258","author":"W Apeng","year":"2023","unstructured":"Apeng, W. et al. Yu, lu. Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety. Eur. J. Med. Chem. 258, 115545. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115545 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"11516_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.phytol.2023.01.004","volume":"53","author":"J Suwichada","year":"2023","unstructured":"Suwichada, J. et al. Synthesis of Piperine analogues as ache and BChE inhibitors for the treatment of alzheimer\u2019s disease. Phytochem. Lett. 53, 216\u2013221. https:\/\/doi.org\/10.1016\/j.phytol.2023.01.004 (2023).","journal-title":"Phytochem. Lett."},{"issue":"25","key":"11516_CR25","doi-asserted-by":"publisher","first-page":"15213","DOI":"10.1039\/d1ra00341k","volume":"11","author":"M Jalageri","year":"2021","unstructured":"Jalageri, M., Nagaraja, D. & Puttaiahgowda, A. Piperazine based antimicrobial polymers: a review. RSC Adv. 11 (25), 15213\u201315230. https:\/\/doi.org\/10.1039\/d1ra00341k (2021).","journal-title":"RSC Adv."},{"key":"11516_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/10426507.2018.1452229","volume":"193","author":"S Nayb-Rasool","year":"2018","unstructured":"Nayb-Rasool, S., Subramanyam, K., Janakiramudu, C., Supraja, D. B. & Usha, P. Raju, C, N. Convenient one-pot synthesis and biological evaluation of phosphoramidates and phosphonates containing heterocycles. Phosphorus Sulfur Silicon Relat. Elem. 193, 470\u2013474. https:\/\/doi.org\/10.1080\/10426507.2018.1452229 (2018).","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"11516_CR27","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1021\/acsomega.1c06527","volume":"7","author":"P Katarzyna","year":"2022","unstructured":"Katarzyna, P. et al. M\u00e1t\u00e9, erd\u00e9lyi. Metallo-\u03b2-Lactamase inhibitor phosphonamidate monoesters. ACS Omega. 7, 5, 4550\u20134562. https:\/\/doi.org\/10.1021\/acsomega.1c06527 (2022).","journal-title":"ACS Omega"},{"key":"11516_CR28","doi-asserted-by":"publisher","first-page":"595738","DOI":"10.3389\/fchem.2020.595738","volume":"8","author":"A Kraszewski","year":"2020","unstructured":"Kraszewski, A., Sobkowski, M. & Stawinski, J. H-Phosphonate chemistry in the synthesis of electrically neutral and charged antiviral and anticancer pronucleotides. Front. Chem. 8, 595738. https:\/\/doi.org\/10.3389\/fchem.2020.595738 (2020).","journal-title":"Front. Chem."},{"key":"11516_CR29","doi-asserted-by":"publisher","first-page":"204020661877524","DOI":"10.1177\/2040206618775243","volume":"26","author":"M Slusarczyk","year":"2018","unstructured":"Slusarczyk, M., Serpi, M. & Pertusati, F. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity. Antiviral Chem. Chemother. 26, 2040206618775243. https:\/\/doi.org\/10.1177\/2040206618775243 (2018).","journal-title":"Antiviral Chem. Chemother."},{"key":"11516_CR30","doi-asserted-by":"publisher","first-page":"104280","DOI":"10.1016\/j.bioorg.2020.104280","volume":"105","author":"M Christiana","year":"2020","unstructured":"Christiana, M. et al. Synthesis and anti-parasitic activity of N-benzylated phosphoramidate Mg2+ chelating ligands. Bioorg. Chem. 105, 104280. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104280 (2020).","journal-title":"Bioorg. Chem."},{"issue":"5","key":"11516_CR31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/jac\/dkw548","volume":"72","author":"E Van","year":"2017","unstructured":"Van, E., Wittekoek, E., Kuijper, B. & Smits, E. J. DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. J. Antimicrob. Chemother. 72 (5), 1275\u20131284. https:\/\/doi.org\/10.1093\/jac\/dkw548 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"11516_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152607780090748","volume":"7","author":"Y Tse-Dinh","year":"2007","unstructured":"Tse-Dinh, Y. & Exploring, C. DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases. Infect. Disord Drug Targets. 7, 1, 3\u20139. https:\/\/doi.org\/10.2174\/187152607780090748 (2007).","journal-title":"Infect. Disord Drug Targets"},{"key":"11516_CR33","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.biopha.2018.04.021","volume":"103","author":"K Tabassum","year":"2018","unstructured":"Tabassum, K. et al. Dravyakar. DNA gyrase inhibitors: progress and synthesis of potent compounds as antibacterial agents. Biomed. Pharmacother. 103, 923\u2013938. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.021 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"11516_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0966-842X(96)10085-8","volume":"3","author":"M Anthony","year":"1997","unstructured":"Anthony, M. DNA gyrase as a drug target. Trends Microbiol. 5. 3, 102\u2013109. https:\/\/doi.org\/10.1016\/S0966-842X(96)10085-8 (1997).","journal-title":"Trends Microbiol. 5"},{"key":"11516_CR35","unstructured":"Murray, P., Baron, R., Pfaller, E. J., Tenover, M. A. & Yolken, F. C. R, H. Manual of Clinical Microbiology, 6th Edition. Mosby Year Book, London, (1995)."},{"key":"11516_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s10593-015-1660-2","volume":"51","author":"D Suresh, Babu","year":"2015","unstructured":"Suresh, Babu, D., Srinivasulu, D. & Venkata, Subbaiah, K. Synthesis of novel N-aryl-4-[6-(2-fluoropyridin-3-yl)-quinazolin-2-yl]-piperazine-1-carboxamideorcarbothioamide derivatives and their antimicrobial activity. Chem. Heterocycl. Compd. 51, 60\u201366. https:\/\/doi.org\/10.1007\/s10593-015-1660-2 (2015).","journal-title":"Chem. Heterocycl. Compd."},{"key":"11516_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.31788\/RJC.2023.1618008","volume":"16","author":"D Suresh, Babu","year":"2023","unstructured":"Suresh, Babu, D. et al. Synthesis and evaluation of some new substituted Piperazinyl-Aryl amide, acetamide and sulfonamide derivatives of Rosuvastatin intermediate and their antimicrobial activity. Rasayan J. Chem. 16, 527\u2013535. https:\/\/doi.org\/10.31788\/RJC.2023.1618008 (2023).","journal-title":"Rasayan J. Chem."},{"key":"11516_CR38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.14233\/ajchem.2025.32973","volume":"37","author":"K Sajitha","year":"2025","unstructured":"Sajitha, K. et al. Jyothi, N, V, V. Design synthesis and in Silico study of Diarylsulfide Piperazine-Amide hybridsas antibacterial motifs. Asian J. Chem. 37, 166\u2013176. https:\/\/doi.org\/10.14233\/ajchem.2025.32973 (2025).","journal-title":"Asian J. Chem."},{"key":"11516_CR39","doi-asserted-by":"publisher","first-page":"0260853","DOI":"10.1371\/journal.pone.0260853","volume":"16","author":"M Bitew","year":"2021","unstructured":"Bitew, M. et al. Pharmacokinetics and Drug-Likeness of antidiabetic flavonoids: molecular Docking and DFT study. PLoS One. 16, 0260853 (2021).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11516-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:22:17Z","timestamp":1759242137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11516-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11516"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11516-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have declared no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of competing interest"}}],"article-number":"33964"}}